Immunoassays
Company expands portfolio of next-generation sequencing immuno-oncology and liquid biopsy assays to meet demand for a multi-disciplinary approach to cancer research
| 4 min read
ASU Biodesign researcher receives $1.2M grant to develop one simple test instead of the ten used now on each sample
| 4 min read
With the range of options available, most scientists can find something that fits many—if not all—of their needs in automating immunoassays.
| 4 min read
- EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, recently announced a partnership with Gyros AB to develop, manufacture and commercialize immunoassay kits for the Gyrolab™ platform.
| 1 min read
